President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

Nebraska will become the first state to implement new work requirements for some people with Medicaid health insurance under ...

A new Department of Health and Human Services report reveals Medicaid programs made over $200 million in improper payments to ...

The deal adds some of the biggest names in drug manufacturing to the president's "most favored nation" pricing plan.

Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis ...

HHS proposes blocking Medicare and Medicaid funding for gender transition procedures on patients under 18, with Robert F.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

President Donald Trump has secured a sweeping set of drug pricing concessions that reach deep into both Medicare and Medicaid ...

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.

Under the administration’s proposal, hospitals that provide such care would lose vital Medicare and Medicaid dollars.

U.S. officials are proposing new restrictions that are designed to effectively ban gender-affirming care for minors ...